Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Inbrija
(levodopa)
Uses, side effects, dosage information & price range
About this medicine
Inbrija is indicated for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinsons disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor.
Common Brand Names for this Composition
The following popular commercial brand names contain levodopa as their active ingredient composition:
Syndopa Plus Tablet
Sun Pharmaceutical Industries Ltd
Syndopa 110 Tablet
Sun Pharmaceutical Industries Ltd
Syndopa CR Tablet
Sun Pharmaceutical Industries Ltd
Syndopa 275 Tablet
Sun Pharmaceutical Industries Ltd
Syncapone 100 Tablet
Sun Pharmaceutical Industries Ltd
Madopar 250 Tablet
Abbott
Onerji
Tanabe Pharma GmbH
Inbrija
Merz Therapeutics GmbH
Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz)
Orion Corporation
Levodopa/Carbidopa/Entacapone Orion
Orion Corporation
Stalevo
Orion Corporation
Numient
Amneal Pharma Europe Ltd
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
levodopa
Category
Anti-Parkinson drugs
Manufacturer
Merz Therapeutics GmbH
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.